Citigroup Inc Xoma Corp Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Xoma Corp stock. As of the latest transaction made, Citigroup Inc holds 1,768 shares of XOMA stock, worth $45,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,768

Previous 1,371 28.96%

Holding current value

$45,968

Previous $32,000 28.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$22.31 - $26.7 $8,857 - $10,599	397 Added 28.96%	1,768 $41,000
Q1 2024 May 10, 2024	BUY	$19.1 - $26.32 $6,245 - $8,606	327 Added 31.32%	1,371 $32,000
Q4 2023 Feb 09, 2024	BUY	$13.82 - $19.13 $14,372 - $19,895	1,040 Added 26000.0%	1,044 $19,000
Q3 2023 Nov 09, 2023	SELL	$14.02 - $17.71 $30,437 - $38,448	-2,171 Reduced 99.82%	4 $0
Q2 2023 Aug 10, 2023	SELL	$17.0 - $21.58 $304,759 - $386,864	-17,927 Reduced 89.18%	2,175 $41,000
Q1 2023 May 11, 2023	BUY	$18.01 - $23.12 $54,732 - $70,261	3,039 Added 17.81%	20,102 $424,000
Q4 2022 Feb 09, 2023	BUY	$16.0 - $25.45 $243,152 - $386,763	15,197 Added 814.42%	17,063 $313,000
Q3 2022 Nov 10, 2022	BUY	$15.9 - $29.56 $28,333 - $52,675	1,782 Added 2121.43%	1,866 $33,000
Q2 2022 Aug 10, 2022	SELL	$17.05 - $28.22 $50,791 - $84,067	-2,979 Reduced 97.26%	84 $2,000
Q1 2022 May 12, 2022	BUY	$19.62 - $29.61 $30,116 - $45,451	1,535 Added 100.46%	3,063 $86,000
Q4 2021 Feb 10, 2022	BUY	$20.04 - $27.57 $16,573 - $22,800	827 Added 117.97%	1,528 $32,000
Q3 2021 Nov 10, 2021	BUY	$23.51 - $34.79 $16,480 - $24,387	701 New	701 $17,000

Others Institutions Holding XOMA

# of Institutions

Shares Held

6.45M

Call Options Held

Put Options Held

2.2K

View Full List

About XOMA Corp

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $298M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

More about XOMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account